Table 1 Average scores of cardiovascular baseline components before treatment measured during the two sessions of treatments between SMT and SHAM
Autonomic cardiac components (n = 17) | SMT (n = 10) | SHAM (n = 7) | Significance |
|---|---|---|---|
RR period (ms) | 826 (47) | 847 (43) | 0.481 |
RMSSD (ms) | 38.9 (2.18) | 39.2 (2.3) | 0.931 |
Log LF-RR (ms2) | 3.08 (0.06) | 3.10 (0.09) | 0.652 |
Log HF-RR (ms2) | 3.00 (0.04) | 3.10 (0.04) | 0.151 |
LF/HF | 1.26 (0.15) | 1.08 (0.16) | 0.429 |
100.LF/(LF + HF) % | 54.3 (2.7) | 50.4 (3.5) | 0.393 |
100.HF/(LF + HF) % | 46.7 (2.7) | 49.6 (3.5) | 0.393 |
SBP (mm Hg) | 118 (4) | 122 (2) | 0.422 |
LF-SBP (mm2Hg) | 11.15 (0.75) | 12.78 (0.71) | 0.151 |
HF-SBP (mm2Hg) | 1.44 (0.31) | 2.02 (0.39) | 0.254 |
LF-BRS gain | 14.20 (1.12) | 13.84 (1.05) | 0.826 |
HF-BRS gain | 20.21 (2.35) | 21.42 (2.10) | 0.720 |